0000000000143616

AUTHOR

Michael H. Olsen

showing 5 related works from this author

A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations ; The Lancet Commi…

2016

Elevated blood pressure is the strongest modifiable risk factor for cardiovascular disease worldwide. Despite extensive knowledge about ways to prevent as well as to treat hypertension, the global incidence and prevalence of hypertension and, more importantly, its cardiovascular complications are not reduced—partly because of inadequacies in prevention, diagnosis, and control of the disorder in an ageing world. The aim of the Lancet Commission on hypertension is to identify key actions to improve the management of blood pressure both at the population and the individual level, and to generate a campaign to adopt the suggested actions at national levels to reduce the impact of elevated blood…

medicine.medical_specialtyEvidence-based practicePopulationBlood PressureGuidelines as TopicDiseaseCommission030204 cardiovascular system & hematologyGlobal HealthGlobal Burden of Disease03 medical and health sciences0302 clinical medicineRaised blood pressureRisk FactorsGlobal healthHumansMedicine030212 general & internal medicineeducationIntensive care medicineeducation.field_of_studybusiness.industryGeneral MedicineLifecourseRisk factor (computing)Call to actionSurgeryBlood pressureHypertensionbusiness
researchProduct

Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure

2011

Aims The aim of the present study was to extend our understanding of international trends in stroke and major sequelae in Europe and countries peripheral to Europe by assessing: (1) current mortality rates, (2) the most recent 15-year prevalence trends, and (3) the relationship between systolic blood pressure in community surveys and national stroke mortality. Methods and results Data were obtained from the World Health Organization (WHO [www.who.int/whosis/database/mort/table.cfm][1]), and represent national vital statistics as reported by 39 countries (European and Central Asian countries) using a standard format and population-based cardiovascular surveys. Total numbers of deaths by stro…

MaleGerontologyPopulationCentral asiaInternational inequalityStroke mortalityGroup BTrials stroke mortality hypertensionAge DistributionResidence CharacteristicsPrevalencemedicineHumansMortalityeducationStrokeAgededucation.field_of_studybusiness.industryMortality rateMiddle Agedmedicine.diseaseEuropeStrokeBlood pressureHypertensionAsia CentralFemaleCardiology and Cardiovascular MedicinebusinessDemography
researchProduct

Agreement within Europe about antihypertensive treatment and education – results from the European Society of Hypertension questionnaire

2010

medicine.medical_specialtyPediatricsPhysiologybusiness.industrymedia_common.quotation_subjectMEDLINEAgreementEuropeFamily medicineHypertensionPractice Guidelines as TopicInternal MedicinemedicineHumansMulticenter Studies as TopicCardiology and Cardiovascular MedicinebusinessAntihypertensive Agentsmedia_commonJournal of Hypertension
researchProduct

Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document

2009

Abbreviations ACE: angiotensin-converting enzyme; BP: blood pressure; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; ESC: European Society of Cardiology; ESH: European Society of Hypertension; ET: endothelin; IMT: carotid intima-media thickness; JNC: Joint National Commit

medicine.medical_specialtymanagement arterial hypertensionPhysiologyupdateRenal functionBlood PressureInternal medicinemedicineInternal MedicineHumanscardiovascular diseasesAntihypertensive AgentsTask forcebusiness.industryHypertension GuidelineHypertension managementGeneral MedicineEuropeOrgan damageBlood pressureHypertensionPractice Guidelines as Topiccardiovascular systemCardiologyMED/09 - MEDICINA INTERNAbusinessEndothelin receptorCardiology and Cardiovascular Medicine
researchProduct

Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk:An International …

2017

Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99. mm. Hg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular mortality ≥1% and <5% at 10 years) absolute total cardiovascular risk (CVR) should be treated with antihypertensive agents. A virtual international consultation process was undertaken to summarize the opinions of select experts. After holistic analysis of all epidemiological, clinical, psychosocial, and public health elements, this consultation process reached the following consensus in hypertensive adults aged <80 years: (1) The question of whether drug treat…

AdultMaleRiskmedicine.medical_specialtyPediatricsEvidence-based practiceHeart Diseasesmedicine.drug_classMEDLINE030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineHypertension/complicationsEpidemiologymedicineHumans030212 general & internal medicineRisk factorAntihypertensive drugAntihypertensive AgentsDisease burdenAntihypertensive Agents/therapeutic usebusiness.industryPublic healthHeart Diseases/etiologyGeneral MedicineHypertensionFemaleCardiology and Cardiovascular MedicinebusinessPsychosocial
researchProduct